{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:18:37Z","timestamp":1792685917907,"version":"4.5.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000861","name":"Sparks","doi-asserted-by":"publisher","award":["14GOU01"],"award-info":[{"award-number":["14GOU01"]}],"id":[{"id":"10.13039\/501100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hematopoietic stem cell transplantation (HSCT) has been proposed as a promising therapeutic opportunity to improve immunity and prevent hematologic malignancies in Ataxia-telangiectasia (A-T). However, experience in the transplantation strategy for A-T patients is still scarce. The aim of this study was to investigate whether different approaches of HSCT are feasible in regard to graft versus host response and sufficient concerning functional immune reconstitution. <jats:italic>Atm<\/jats:italic>-deficient mice were treated with a clinically relevant non-myeloablative host-conditioning regimen and transplanted with CD90.2-depleted, green fluorescent protein (GFP)-expressing, and ataxia telangiectasia mutated (ATM)-competent bone marrow donor cells in a syngeneic, haploidentical or allogeneic setting. Like syngeneic HSCT, haploidentical HSCT, but not allogeneic HSCT extended the lifespan of <jats:italic>Atm<\/jats:italic>-deficient mice through the reduction of thymic tumors and normalized T-cell numbers. Donor-derived splenocytes isolated from transplanted <jats:italic>Atm<\/jats:italic>-deficient mice filled the gap of cell loss in the na\u00efve T-cell population and raised CD4 cell functionality up to wild-type level. Interestingly, HSCT using heterozygous donor cells let to a significantly improved survival of <jats:italic>Atm<\/jats:italic>-deficient mice and increased CD4 cell numbers as well as CD4 cell functionality equivalent to HSCT using with wild-type donor cells. Our data provided evidence that haploidentical HSCT could be a feasible strategy for A-T, possibly even if the donor is heterozygous for ATM. However, this basic research cannot substitute any research in humans.<\/jats:p>","DOI":"10.3389\/fimmu.2021.693897","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T07:15:13Z","timestamp":1624950913000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Survival and Functional Immune Reconstitution After Haploidentical Stem Cell Transplantation in Atm-Deficient Mice"],"prefix":"10.3389","volume":"12","author":[{"given":"Ruth Pia","family":"Duecker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Gronau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"B1","article-title":"Ataxia-Telangiectasia; A Familial Syndrome of Progressive Cerebellar Ataxia, Oculocutaneous Telangiectasia and Frequent Pulmonary Infection","volume":"21","author":"Boder","year":"1958","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01830.x","article-title":"Deficiencies in CD4+ and CD8+ T Cell Subsets in Ataxia Telangiectasia","volume":"129","author":"Schubert","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jaci.2013.01.053","article-title":"Antibody Deficiency in Patients With Ataxia Telangiectasia is Caused by Disturbed B- and T-Cell Homeostasis and Reduced Immune Repertoire Diversity","volume":"131","author":"Driessen","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/336577a0","article-title":"Localization of an Ataxia-Telangiectasia Gene to Chromosome 11q22-23","volume":"336","author":"Gatti","year":"1988","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A Single Ataxia Telangiectasia Gene With a Product Similar to PI-3 Kinase","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2514","article-title":"Ataxia-Telangiectasia: From a Rare Disorder to a Paradigm for Cell Signalling and Cancer","volume":"9","author":"Lavin","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112263252602","article-title":"Incidence of Cancer in 161 Families Affected by Ataxia-Telangiectasia","volume":"325","author":"Swift","year":"1991","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.03.052","article-title":"Morbidity and Mortality From Ataxia-Telangiectasia Are Associated With ATM Genotype","volume":"128","author":"Micol","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21277","article-title":"Evaluation and Management of Pulmonary Disease in Ataxia-Telangiectasia","volume":"45","author":"McGrath-Morrow","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM Protein Kinase: Regulating the Cellular Response to Genotoxic Stress, and More","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.2.423.bloodjournal872423","article-title":"Leukemia and Lymphoma in Ataxia Telangiectasia","volume":"87","author":"Taylor","year":"1996","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41419-018-0357-8","article-title":"Atm Reactivation Reverses Ataxia Telangiectasia Phenotypes In Vivo","volume":"9","author":"Di Siena","year":"2018","journal-title":"Cell Death Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4226","article-title":"Bone Marrow Transplantation Restores Immune System Function and Prevents Lymphoma in Atm-Deficient Mice","volume":"104","author":"Bagley","year":"2004","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02785","article-title":"Hematopoietic Stem Cell Transplantation Restores Na\u00efve T-Cell Populations in Atm-Deficient Mice and in Preemptively Treated Patients With Ataxia-Telangiectasia","volume":"10","author":"Duecker","year":"2019","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02495","article-title":"Pre-Emptive Allogeneic Hematopoietic Stem Cell Transplantation in Ataxia Telangiectasia","volume":"9","author":"Bakhtiar","year":"2018","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.12.493","article-title":"Lifetime Probabilities of Hematopoietic Stem Cell Transplantation in the U.S","volume":"14","author":"Nietfeld","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2016.1167204","article-title":"Advances in Haploidentical Stem Cell Transplantation for Hematologic Malignancies","volume":"57","author":"Montoro","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0022-1759(98)00204-x","article-title":"An Advanced Culture Method for Generating Large Quantities of Highly Pure Dendritic Cells From Mouse Bone Marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J Immunol Methods"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)80086-0","article-title":"Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasia","volume":"86","author":"Barlow","year":"1996","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/hmg\/dds448","article-title":"Bone Marrow Transplantation Improves the Outcome of Atm-Deficient Mice Through the Migration of ATM-Competent Cells","volume":"22","author":"Pietzner","year":"2013","journal-title":"Hum Mol Genet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230","article-title":"An Experimental Model of Idiopathic Pneumonia Syndrome After Bone Marrow Transplantation: I","volume":"88","author":"Cooke","year":"1996","journal-title":"roles minor H Antigens Endotoxin. Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0611222104","article-title":"ATM Deficiency Impairs Thymocyte Maturation Because of Defective Resolution of T Cell Receptor Alpha Locus Coding End Breaks","volume":"104","author":"Vacchio","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403221","article-title":"ATM Gene and Lymphoid Malignancies","volume":"18","author":"Gumy-Pause","year":"2004","journal-title":"Leukemia"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.02.036","article-title":"Outcome of Hematopoietic Cell Transplantation for DNA Double-Strand Break Repair Disorders","volume":"141","author":"Slack","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.207","article-title":"Successful SCT for Nijmegen Breakage Syndrome","volume":"45","author":"Albert","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.08.015","article-title":"The Saudi Experience in Fludarabine-Based Conditioning Regimens in Patients With Fanconi Anemia Undergoing Stem Cell Transplantation: Excellent Outcome in Recipients of Matched Related Stem Cells But Not in Recipients of Unrelated Cord Blood Stem Cells","volume":"18","author":"Ayas","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-479733","article-title":"Allogeneic Hematopoietic Stem Cell Transplantation in Fanconi Anemia: The European Group for Blood and Marrow Transplantation Experience","volume":"122","author":"Peffault de Latour","year":"2013","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.07.001","article-title":"Allogeneic Stem Cell Transplantation After Fanconi Anemia Conditioning in Children With Ataxia-Telangiectasia Results in Stable T Cell Engraftment and Lack of Infections Despite Mixed Chimerism","volume":"24","author":"Ussowicz","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.3390\/cancers12113207","article-title":"Bone Marrow Transplantation as Therapy for Ataxia-Telangiectasia: A Systematic Review","volume":"12","author":"Sabino Pinho de Oliveira","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-017-0394-2","article-title":"A Comparison Between Allogeneic Stem Cell Transplantation From Unmanipulated Haploidentical and Unrelated Donors in Acute Leukemia","volume":"10","author":"Piemontese","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.34","article-title":"Use of Haploidentical Stem Cell Transplantation Continues to Increase: The 2015 European Society for Blood and Marrow Transplant Activity Survey Report","volume":"52","author":"Passweg","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"B32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3349\/ymj.2007.48.1.11","article-title":"The HLA System: Genetics, Immunology, Clinical Testing, and Clinical Implications","volume":"48","author":"Choo","year":"2007","journal-title":"Yonsei Med J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2012.1.230","article-title":"Haploidentical Transplantation for Hematologic Malignancies: Where do We Stand","volume":"2012","author":"Fuchs","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.09.023","article-title":"The Biology of Chronic Graft-Versus-Host Disease: A Task Force Report From the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease","volume":"23","author":"Cooke","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.75","article-title":"Primary Graft Failure After Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies","volume":"29","author":"Olsson","year":"2015","journal-title":"Leukemia"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1084\/jem.166.5.1280","article-title":"Tumor Necrosis Factor\/Cachectin is an Effector of Skin and Gut Lesions of the Acute Phase of Graft-vs.-Host Disease","volume":"166","author":"Piguet","year":"1987","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.11.001","article-title":"Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States","volume":"22","author":"Apperley","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","article-title":"The Primacy of the Gastrointestinal Tract as a Target Organ of Acute Graft-Versus-Host Disease: Rationale for the Use of Cytokine Shields in Allogeneic Bone Marrow Transplantation","volume":"95","author":"Hill","year":"2000","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jaci.2017.11.050","article-title":"T-Cell Gene Therapy for Perforin Deficiency Corrects Cytotoxicity Defects and Prevents Hemophagocytic Lymphohistiocytosis Manifestations","volume":"142","author":"Ghosh","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5726132","article-title":"Review on Haploidentical Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies","volume":"2016","author":"Fabricius","year":"2016","journal-title":"Adv Hematol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.23.13084","article-title":"Pleiotropic Defects in Ataxia-Telangiectasia Protein-Deficient Mice","volume":"93","author":"Elson","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1111\/cge.12710","article-title":"Health Risks for Ataxia-Telangiectasia Mutated Heterozygotes: A\u00a0Systematic Review, Meta-Analysis and Evidence-Based Guideline","volume-title":"Clin Genet","author":"van Os","year":"2016"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.693897\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T07:15:18Z","timestamp":1624950918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.693897\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2021.693897"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.693897","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"article-number":"693897"}}